Message from the President
Hi. I am Dr. Maurizio Fava. I am truly honored to serve as President of the American Society of Clinical Psychopharmacology, or “ASCP.” ASCP was founded in 1992 by a group of psychopharmacologists who believed that there was a strong need for an organization focusing on the clinical practice of psychopharmacology. The mission of the ASCP is to advance the science and practice of clinical psychopharmacology. The members of ASCP are physicians in psychopharmacologic practice and research, and doctoral level scientists involved in active clinical investigation in the field.
I am personally very grateful to Dr. John Kane, the ASCP past-president, for the incredible leadership and commitment he has displayed over the past 10 years as president. John is certainly a very tough act to follow. I have been a member of this organization for the past two decades and, for the past few years, I have had the opportunity to serve on its board and to see its wonderful evolution over the years. I am proud to be a psychopharmacologist and to be a member of this society. Psychopharmacology is an exciting field undergoing dramatic changes, with the identification of new molecular targets and the development of novel compounds. Our Society needs to keep its members abreast of such innovations and to use the ASCP annual meetings as a vehicle for the dissemination of cutting edge psychopharmacology research. We also need to develop ways to make our members feel more connected with our Society and to include more clinically focused symposia. We also need to make our Society more known to those who are interested in and practice psychopharmacology, so that the overall membership can continue to grow.
ASCP has a number of activities which your may explore on our website. For example, we have 4 meetings per year. One of our annual meetings is a Clinical Trials Workshop. This workshop is geared towards young investigators, but practicing clinicians who wish to participate in clinical psychopharmacology research have also found it very useful. There are lectures on basic research methodology, statistics, and the practicalities of becoming involved as an investigator in clinical trials.
In 2014 the Clinical Trials Workshop will take place just after the ASCP (NCDEU) Annual Meeting, June 19-21, 2014. Our fall meeting, which includes the annual membership meeting, is a world-class update on psychopharmacology, taking place in New York City. The program is designed to provide state-of-the-art education on new developments in the field for clinicians already knowledgeable about drug treatment of psychiatric disorders. It’s held on a weekend, so busy clinicians can more easily attend this jam-packed 2 day educational event.
Our winter meeting is another world-class update on psychopharmacology, taking place in San Diego, CA. The program is also designed to provide state-of-the-art education on new developments in the field for clinicians already knowledgeable about drug treatment of psychiatric disorders. We hope by offering this meeting on the west coast we can grow our membership and serve a broader constituency.
The ASCP (NCDEU) Annual Meeting is an outstanding scientific meeting focusing on new psychopharmacology and neurobiology research. The program includes presentations and information from ASCP and its federal partners, the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism, (NIAAA) and the Food and Drug Administration (FDA). It takes place typically at the end of May or early June in Florida and it is a meeting very rich of novel and state of the art psychopharmacological research findings.
Of course, ASCP members receive discounts on these meetings, and other activities of the Society.
Our society is associated with the Journal of Clinical Psychiatry. As the official journal of ASCP, the Society is represented on the editorial board, and publishes its own “ASCP Corner” page every month. Members receive the paper journal free and may subscribe to the online edition at a markedly discounted cost.
ASCP is also the publisher of a residency training curriculum in psychopharmacology, which is quickly becoming a standard in psychiatry residency education across the country. We have released similar curricula for primary care physicians and medical students.
ASCP is all about education. If you are a physician in any specialty, or are a doctoral level scientist involved in active clinical psychopharmacological investigation, we hope that you’ll join the Society. Dues are $100 per year (dues are waived for residents and fellows). We have lots of plans for the future which I think you’ll both enjoy and benefit from professionally. Look through this website to learn more about us. Please contact our office if you have questions about the Society.